Patents

Description

DERIVATI DE FENILCARBONILUREE SI COMPOZITIE FARMACEUTICA

Price not visible for this package

Interest:

Assignment

Publication info:

No.: RO118290

Date: 30.04.2003

Inventor(s):

RUMINSKI PETER GERRARD [US]

CLARE MICHAEL [US]

COLLINS PAUL WADDELL [US]

DESAI BIPINCHANDRA NANUBHAI [US]

LINDMARK RICHARD J [US]

RICO JOSEPH GERACE [US]

ROGERS THOMAS EDWARD [US]

RUSSELL MARK ANDREW [US]

Applicant(s):
GDSEARLE & CO [US]
Classification:
International patent classification (IPC):
A61K31/00; A61K31/155; A61K31/17; A61K31/195; A61K31/24; A61K31/335; A61K31/34; A61K31/341; A61K31/343; A61K31/357; A61K31/36; A61K31/38; A61K31/40; A61K31/403; A61K31/404; A61K31/4045; A61K31/41; A61K31/415; A61K31/4164; A61K31/4168; A61K31/4184; A61K31/4196; A61K31/44; A61K31/4406; A61K31/445; A61K31/4453; A61K31/4458; A61K31/47; A61K31/505; A61K31/513; A61K31/535; A61K31/5375; A61K31/54; A61K31/541; A61K31/70; A61K31/7028; A61K31/7034; A61K38/00; A61P25/06; A61P35/00; A61P35/04; A61P43/00; A61P5/38; C07C275/28; C07C275/42; C07C279/18; C07C279/24; C07C279/28; C07C311/19; C07C311/37; C07C313/34; C07C317/50; C07C323/59; C07C323/62; C07C323/63; C07C335/22; C07C335/28; C07D207/14; C07D207/22; C07D209/16; C07D211/72; C07D213/55; C07D213/61; C07D213/74; C07D215/14; C07D223/12; C07D231/06; C07D231/12; C07D231/14; C07D233/50; C07D233/64; C07D235/30; C07D239/14; C07D239/26; C07D239/54; C07D239/545; C07D249/14; C07D295/12; C07D295/14; C07D295/20; C07D295/215; C07D295/22; C07D307/54; C07D307/79; C07D307/81; C07D317/60; C07D317/64; C07D319/18; C07D319/20; C07D333/20; C07D333/24; C07D333/28; C07D401/12; C07D401/14; C07D405/10; C07D405/12; C07D413/12; C07D417/12; C07H15/203; C07K5/062; A61K31/395; C07D207/16
Cooperative patent classification (CPC):
A61P19/00 (EP); A61P25/06 (EP); A61P35/00 (EP); A61P35/04 (EP); A61P43/00 (EP); A61P5/38 (EP); C07C275/42 (EP, US); C07C279/18 (EP, US); C07C279/24 (EP, US); C07C279/28 (EP, US); C07C311/19 (EP, US); C07C311/37 (EP, US); C07C317/50 (EP, US); C07C323/59 (EP, US); C07C323/62 (EP, US); C07C323/63 (EP, US); C07C335/22 (EP, US); C07C335/28 (EP, US); C07D207/14 (EP, US); C07D211/72 (EP, US); C07D213/55 (EP, US); C07D213/56 (KR); C07D213/61 (EP, US); C07D215/14 (EP, US); C07D223/12 (EP, US); C07D231/06 (EP, US); C07D231/12 (EP, US); C07D231/14 (EP, US); C07D233/50 (EP, US); C07D239/14 (EP, US); C07D239/26 (EP, US); C07D239/545 (EP, US); C07D249/14 (EP, US); C07D295/215 (EP, US); C07D307/54 (EP, US); C07D307/79 (EP, US); C07D307/81 (EP, US); C07D317/60 (EP, US); C07D319/18 (EP, US); C07D333/24 (EP, US); C07D333/28 (EP, US); C07D401/12 (EP, US); C07D401/14 (EP, US); C07D405/12 (EP, US); C07D413/12 (EP, US); C07D417/12 (EP, US); C07H15/203 (EP, US)
Application info:
No.: RO19200101069
Date: 27.08.1996
Priority number(s):
US19950003277P 30.08.1995
Related patents:
ATE203234; AU702487; AU7103996; BR9610422; CA2230209; CN1085980; CN1201454; CZ293323; CZ34198; DE69613985; DK0850221; EP0850221; ES2161373; GR3036751; IL123164; JPH11510814; KR100481285; KR19990063584; MX9801716; NO311671; NO980817; NZ318926; PL186370; PL325312; PT850221; RO118289; RU2196769; US6028223; US6831199; WO9708145; ZA967379
Description:

Prezenta inventie se refera la o clasa de compusi reprezentati prin formula generala: sau la o sare acceptabila farmaceutic, in care A este: la compozitiile farmaceutice, continand acesti compusi, si la metoda pentru prevenirea sau tratarea unei afectiuni mediate de alfav beta3 integrina, utilizand compusii si/sau compozitiile conform inventiei.

cover
Share this on:
Facebook Twitter/X LinkedIn Whatsapp Email